UK markets closed

Veracyte, Inc. (VCYT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.37+0.74 (+3.59%)
At close: 04:00PM EDT
21.66 +0.29 (+1.36%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
375,473
361,051
296,536
219,514
117,483
Cost of revenue
118,135
112,903
101,582
74,400
41,455
Gross profit
257,338
248,148
194,954
145,114
76,028
Operating expenses
Research development
60,501
57,305
40,603
29,843
17,204
Selling general and administrative
186,787
184,232
168,515
181,193
89,118
Total operating expenses
269,791
265,023
230,294
225,482
111,417
Operating income or loss
-12,453
-16,875
-35,340
-80,368
-35,389
Interest expense
8
15
198
241
229
Total other income/expenses net
-66,818
-67,066
-2,861
-1,175
115
Income before tax
-70,429
-76,612
-36,427
-81,649
-34,909
Income tax expense
-2,252
-2,208
133
-6,086
0
Income from continuing operations
-68,177
-74,404
-36,560
-75,563
-34,909
Net income
-68,177
-74,404
-36,560
-75,563
-34,909
Net income available to common shareholders
-68,177
-74,404
-36,560
-75,563
-34,909
Basic EPS
-0.69
-1.02
-0.51
-1.11
-0.66
Diluted EPS
-0.69
-1.02
-0.51
-1.11
-0.66
Basic average shares
72,324
72,644
71,549
67,890
53,239
Diluted average shares
72,324
72,644
71,549
67,890
53,239